{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:57:16Z","timestamp":1782867436617,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":121,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Western Medicine-General Guide Item of Guangzhou Municipal Health Commission","award":["20241A011039"],"award-info":[{"award-number":["20241A011039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06498-4","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:57:19Z","timestamp":1772456239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel SPI1 variant (c.566T\u2009&gt;\u2009C (p.Ile189Thr)) possibly associated with autosomal dominant agammaglobulinemia in a Chinese girl"],"prefix":"10.1186","volume":"26","author":[{"given":"Ping","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"3","key":"6498_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00251-024-01342-y","volume":"76","author":"R Khoshnevisan","year":"2024","unstructured":"Khoshnevisan R, Hassanzadeh S, Klein C, et al. B-cells absence in patients diagnosed as inborn errors of immunity: a registry-based study. Immunogenetics. 2024;76(3):189\u2013202.","journal-title":"Immunogenetics"},{"issue":"2","key":"6498_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14712\/18059694.2024.21","volume":"67","author":"A Markocsy","year":"2024","unstructured":"Markocsy A, Kapustov\u00e1 D, \u010cere\u0161 A, et al. Atypical manifestation of X-linked Agammaglobulinemia - the importance of genetic testing. Acta Medica (Hradec Kralove). 2024;67(2):60\u20133.","journal-title":"Acta Medica (Hradec Kralove)"},{"issue":"3","key":"6498_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000527265","volume":"184","author":"EB Karadeniz","year":"2022","unstructured":"Karadeniz EB, Aliyeva C, Aydemir S, et al. Chronic rhinosinusitis in patients with primary immunodeficiency. Int Arch Allergy Immunol. 2022;184(3):302\u201310.","journal-title":"Int Arch Allergy Immunol"},{"key":"6498_CR4","doi-asserted-by":"crossref","unstructured":"Ivankovich-Escoto G, Danielian S, Morera E et al. Clinical immunological and genetic characterization of patients with X-linked agammaglobulinemia in Costa Rica Scandinavian. J Immunol. 2022;97(1):1-10.","DOI":"10.1111\/sji.13237"},{"issue":"1","key":"6498_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-024-01815-5","volume":"45","author":"A Thangaraj","year":"2024","unstructured":"Thangaraj A, Sil A, Goel S, et al. Disseminated aspergillosis in X-linked agammaglobulinemia: beyond the norm. J Clin Immunol. 2024;45(1):24.","journal-title":"J Clin Immunol"},{"issue":"4","key":"6498_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.humimm.2022.01.003","volume":"83","author":"G Madathil Govindaraj","year":"2022","unstructured":"Madathil Govindaraj G, Jain A, Edavazhippurath A, et al. Clinical immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala South India. Hum Immunol. 2022;83(4):335\u201345.","journal-title":"Hum Immunol"},{"key":"6498_CR7","doi-asserted-by":"crossref","unstructured":"Cardenas-Cruz C, Jim\u00e9nez-Santana L, Campos-Lopez D et al. X-linked agammaglobulinemia: 35 years of experience in a tertiary pediatric hospital in Latin America. Int J Contemp Pediatr. 2022;10(3):302-09.","DOI":"10.18203\/2349-3291.ijcp20223151"},{"issue":"4","key":"6498_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10875-022-01222-8","volume":"42","author":"K Altman","year":"2022","unstructured":"Altman K, Zhou C, Hernandez-Trujillo V, et al. Health-Related quality of life in 91 patients with X-Linked agammaglobulinemia. J Clin Immunol. 2022;42(4):811\u20138.","journal-title":"J Clin Immunol"},{"issue":"6","key":"6498_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/uog.14738","volume":"45","author":"Y Yang","year":"2015","unstructured":"Yang Y, Tang H, Li W, et al. Identification by whole-exome sequencing of novel mutation c.64C\u2009>\u2009G in the BTK gene of a fetus with X-linked agammaglobulinemia. Ultrasound Obstet Gynecol. 2015;45(6):753\u20134.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"6498_CR10","first-page":"e69887","volume":"16","author":"K Almutairy","year":"2024","unstructured":"Almutairy K, Alasmari B, Rayees S. Digenic inheritance of hereditary spherocytosis type III and X-linked agammaglobulinemia: coexistence of two distinct recessive disorders in a male child. Cureus. 2024;16(9):e69887.","journal-title":"Cureus"},{"key":"6498_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2019.05.001","volume":"210","author":"Y Bagheri","year":"2019","unstructured":"Bagheri Y, Vosughi A, Azizi G, et al. Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients. Immunol Lett. 2019;210:55\u201362.","journal-title":"Immunol Lett"},{"issue":"3","key":"6498_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4046\/trd.2008.65.3.207","volume":"65","author":"M Chung","year":"2008","unstructured":"Chung M, Jung J, Son J, et al. A case of X-Linked agammaglobulinemia with Btk gene intron 2 mutation. Tuberc Respir Dis. 2008;65(3):207.","journal-title":"Tuberc Respir Dis"},{"key":"6498_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1034\/j.1600-065X.2000.17811.x","volume":"178","author":"T Islam","year":"2000","unstructured":"Islam T, Smith C. The cellular phenotype conditions Btk for cell survival or apoptosis signaling. Immunol Rev. 2000;178:49\u201363.","journal-title":"Immunol Rev"},{"issue":"7","key":"6498_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF03401694","volume":"3","author":"B Saha","year":"1997","unstructured":"Saha B, Curtis S, Vogler L, et al. Molecular and structural characterization of five novel mutations in the bruton\u2019s tyrosine kinase gene from patients with X-linked agammaglobulinemia. Mol Med. 1997;3(7):477\u201385.","journal-title":"Mol Med"},{"issue":"3","key":"6498_CR15","first-page":"471","volume":"67","author":"S Zaidi","year":"2017","unstructured":"Zaidi S, Qureshi S, Qamar F. X-linked agammaglobulinemia - first case with Bruton tyrosine kinase mutation from Pakistan. J Pak Med Assoc. 2017;67(3):471\u20133.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"6498_CR16","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/j.jaci.2005.12.685","volume":"117","author":"S Patel","year":"2006","unstructured":"Patel S, Roberts R. Transient hypogammaglobulinemia of Infancy, a possible autosomal dominant inheritance pattern in certain families. J Allergy Clin Immunol. 2006;117(2):S172.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"6498_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-021-08870-5","volume":"63","author":"M Cardenas-Morales","year":"2021","unstructured":"Cardenas-Morales M, Hernandez-Trujillo VP. Agammaglobulinemia: from X-linked to autosomal forms of disease. Clin Rev Allergy Immunol. 2021;63(1):22\u201335.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"6498_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.gene.6364391","volume":"8","author":"S Ferrari","year":"2007","unstructured":"Ferrari S, Zuntini R, Lougaris V, et al. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia. Genes Immun. 2007;8(4):325\u201333.","journal-title":"Genes Immun"},{"issue":"1","key":"6498_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10875-017-0462-y","volume":"38","author":"P Tang","year":"2017","unstructured":"Tang P, Upton J, Barton-Forbes M, et al. Autosomal recessive agammaglobulinemia due to a homozygous mutation in PIK3R1. J Clin Immunol. 2017;38(1):88\u201395.","journal-title":"J Clin Immunol"},{"key":"6498_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2018.07.016","volume":"198","author":"S Qureshi","year":"2018","unstructured":"Qureshi S, Sheikh M, Qamar FN. Autosomal recessive Agammaglobulinemia - first case with a novel TCF3 mutation from Pakistan. Clin Immunol. 2018;198:100\u20131.","journal-title":"Clin Immunol"},{"issue":"6","key":"6498_CR21","doi-asserted-by":"publisher","first-page":"e13805","DOI":"10.1111\/pai.13805","volume":"33","author":"M Erd\u0151s","year":"2022","unstructured":"Erd\u0151s M, Mironska K, Kareva L, et al. A novel mutation in SLC39A7 identified in a patient with autosomal recessive agammaglobulinemia: the impact of the J project. Pediatr Allergy Immunology-UK. 2022;33(6):e13805.","journal-title":"Pediatr Allergy Immunology-UK"},{"key":"6498_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","volume":"183","author":"B Shillitoe","year":"2017","unstructured":"Shillitoe B, Gennery A. X-Linked agammaglobulinaemia: outcomes in the modern era. Clin Immunol. 2017;183:54\u201362.","journal-title":"Clin Immunol"},{"issue":"7","key":"6498_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/21678707.2017.1330145","volume":"5","author":"F Rahmani","year":"2017","unstructured":"Rahmani F, Aghamohammadi A, Ochs H, et al. Agammaglobulinemia: comorbidities and long-term therapeutic risks. Expert Opin Orphan Drugs. 2017;5(7):559\u201374.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"3","key":"6498_CR24","first-page":"322","volume":"15","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jiang Y, Qi Q, et al. A case of autosomal dominant agammaglobulinemia. Chin J Clin Immun Allergy. 2021;15(3):322\u20134.","journal-title":"Chin J Clin Immun Allergy"},{"issue":"8","key":"6498_CR25","first-page":"700","volume":"59","author":"L Chen","year":"2021","unstructured":"Chen L, Liu J, Yin J, et al. Two Chinese cases with STAT1 gene gain-of-function variation. Chin J Pediatr. 2021;59(8):700\u20132.","journal-title":"Chin J Pediatr"},{"issue":"11","key":"6498_CR26","first-page":"861","volume":"27","author":"C Wang","year":"2020","unstructured":"Wang C, Wang N, Feng J, et al. Two cases of congenital immunodeficiency with disseminated infection of cyanobacteria Marneffei and literature review. Chin J Pediatr Emerg Med. 2020;27(11):861\u20134.","journal-title":"Chin J Pediatr Emerg Med"},{"issue":"4","key":"6498_CR27","first-page":"301","volume":"37","author":"J Zheng","year":"2019","unstructured":"Zheng J, Xiao Y, Liu L, et al. Activated PI3K-\u03b4 syndrome caused by PIK3CD gene mutation: a case report and literature review[J]. J Clin Pediatr. 2019;37(4):301\u20133.","journal-title":"J Clin Pediatr"},{"key":"6498_CR28","volume-title":"PIK3CD gene mutation induced PI3K\u03b4 hyperactivation syndrome in children: a report of 2 cases and literature review","author":"J Wang","year":"2022","unstructured":"Wang J. PIK3CD gene mutation induced PI3K\u03b4 hyperactivation syndrome in children: a report of 2 cases and literature review. Abstract: Qingdao University; 2022."},{"issue":"2","key":"6498_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2023.03.022","volume":"152","author":"A Jauch","year":"2023","unstructured":"Jauch A, Bignucolo O, Seki S, et al. Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency. J Allergy Clin Immunol. 2023;152(2):500\u201316.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"6498_CR30","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410\u20136.","journal-title":"Nat Med"},{"key":"6498_CR31","doi-asserted-by":"publisher","first-page":"1324679","DOI":"10.3389\/fimmu.2024.1324679","volume":"15","author":"R Miskovic","year":"2024","unstructured":"Miskovic R, Ljubicic J, Bonaci-Nikolicet B, et al. Case report: rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia. Front Immunol. 2024;15:1324679.","journal-title":"Front Immunol"},{"issue":"7","key":"6498_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10875-024-01758-x","volume":"44","author":"T Utsumi","year":"2024","unstructured":"Utsumi T, Tsumura M, Yashiroet M, et al. Exclusive characteristics of the p.E555K dominant-Negative variant in autosomal dominant E47 deficiency. J Clin Immunol. 2024;44(7):167.","journal-title":"J Clin Immunol"},{"issue":"19","key":"6498_CR33","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","volume":"124","author":"C Lee","year":"2014","unstructured":"Lee C, Fulcher D, Whittleet B, et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood. 2014;124(19):2964\u201372.","journal-title":"Blood"},{"key":"6498_CR34","doi-asserted-by":"crossref","unstructured":"Le Coz C, Nguyen D, Su C et al. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients. J Exp Med. 2021;218(7):e20211390.","DOI":"10.1084\/jem.20201750"},{"issue":"6","key":"6498_CR35","first-page":"e62983","volume":"16","author":"IJ Syed","year":"2024","unstructured":"Syed IJ, Cipe F, Al-Hammadi S, et al. A novel variant of the PIK3R1 gene mutation associated with SHORT syndrome and agammaglobulinemia. Cureus. 2024;16(6):e62983.","journal-title":"Cureus"},{"issue":"4","key":"6498_CR36","first-page":"452","volume":"23","author":"S Naiboglu","year":"2024","unstructured":"Naiboglu S, Gezdirici A, Ula\u015f S, et al. Single mutation different clinical findings: IGLL1 defect. Iran J Allergy Asthma Immunol. 2024;23(4):452\u20136.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"6498_CR37","first-page":"279","volume":"48","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Zhao X, Wang M, et al. Analysis of mutation in heavy chain-\u00b5 (\u00b5HC) gene in a Chinese patient with congenital agammaglobulinemia. Chin J Pediatr. 2010;48(4):279\u201383.","journal-title":"Chin J Pediatr"},{"issue":"1","key":"6498_CR38","first-page":"55","volume":"57","author":"S Hu","year":"2019","unstructured":"Hu S, Wang Y, Sun Q, et al. [Clinical and genetic manifestations of immunodeficiency centromeric instability and facial anomalies syndrome: a case report and literature review]. Zhonghua Er Ke Za Zhi. 2019;57(1):55\u20139.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"7","key":"6498_CR39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1172\/JCI0215658","volume":"110","author":"E Lopez-Granados","year":"2002","unstructured":"Lopez-Granados E, Porpiglia AS, Hogan MB, et al. Clinical and molecular analysis of patients with defects in micro heavy chain gene. J Clin Invest. 2002;110(7):1029\u201335.","journal-title":"J Clin Invest"},{"issue":"20","key":"6498_CR40","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJM199611143352003","volume":"335","author":"L Yel","year":"1996","unstructured":"Yel L, Minegishi Y, Coustan- Smith E, et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med. 1996;335(20):1486\u201393.","journal-title":"N Engl J Med"},{"key":"6498_CR41","doi-asserted-by":"crossref","unstructured":"Wahlster L, Sankaran VG. I SPI1 something needed for B cells. J Exp Med. 2021;218(7).","DOI":"10.1084\/jem.20210572"},{"issue":"22","key":"6498_CR42","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.2024026683","volume":"145","author":"A Knox","year":"2025","unstructured":"Knox A, Cominsky L, Sun D, et al. One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them. Blood. 2025;145(22):2549\u201360.","journal-title":"Blood"},{"key":"6498_CR43","doi-asserted-by":"crossref","unstructured":"Daddali R, Kettunen K, Turunen T et al. Novel heterozygous SPI1c.538C\u2009>\u2009T p.(Leu180Phe) variant causes PU.1 haploinsufficiency leading to agammaglobulinemia. Clin Immunol. 2025;277:110503.","DOI":"10.1016\/j.clim.2025.110503"},{"key":"6498_CR44","doi-asserted-by":"crossref","unstructured":"Miskovic R, Ljubicic J, Bonaci-Nikolic B et al. Case report: rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia.Frontiers in immunology. 2024;15:1324679.","DOI":"10.3389\/fimmu.2024.1324679"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06498-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:17:28Z","timestamp":1782865048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06498-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6498"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06498-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7538129\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committees of the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong, China. Written informed consent of this study was obtained from her parents of this patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent of this case report obtained from her parents of this patient was approved for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}